BCG 예방 접종 후 발생한 특이 피부 이상반응에 대한 임상 연구 = Clinical Study of Specific Cutaneous Complications after BCG Vaccination

다국어 초록 (Multilingual Abstract)

Background: Bacille Calmette-Guérin (BCG) vaccination has been widely used to prevent severe infections caused by Mycobacterium tuberculosis. Although BCG vaccination is generally safe, some cutaneous complications may occur. However, cutaneous complications related to BCG infection have been rarely investigated in Korea.
Objective: This study aimed to investigate the clinical characteristics of cutaneous complications following BCG vaccination in Korean patients.
Methods: We identified 18 patients with cutaneous complications following BCG vaccination in the Pusan National University Hospitals (Busan and Yangsan) from 2002 to 2019. Clinical manifestations and course were examined by the review of medical records and photographs.
Results: Among BCG-vaccinated persons, 18 patients manifested with BCG-specific cutaneous complications. The mean age of the patients was 10.6±10.1 months, and 10 (55.6%) were female. The specific cutaneous complications following BCG vaccination were local abscess (7, 38.9%), lymphadenitis (4, 22.2%), BCG reactivation in incomplete Kawasaki disease (4, 22.2%), tuberculid (3, 16.7%), and scrofuloderma (1, 5.6%). Disseminated BCG infection was detected in 2 brothers (11.1%) who had an immunocompromised state and a family history of BCG complication.
Conclusion: Specific cutaneous complications after BCG vaccination are rare, but may occur in various manifestations.
(Korean J Dermatol 2020;58(7):453∼458)

참고문헌 (Reference)

1 조혜경, "The Necessity of a Nationwide Surveillance System of Serious BCG Adverse Reactions" 대한의학회 34 (34): 1-2, 2019

2 Sireci G, "T cells recognize an immunodominant epitope of heat shock protein 65 in Kawasaki disease" 6 : 581-590, 2000

3 Milstien JB, "Quality control of BCG vaccine by WHO : a review of factors that may influence vaccine effectiveness and safety" 68 : 93-108, 1990

4 FitzGerald JM, "Management of adverse reactions to bacille Calmette-Guerin vaccine" 31 (31): S75-S76, 2000

5 Casanova JL, "Immunological conditions of children with BCG disseminated infection" 346 : 581-, 1995

6 Newburger JW, "Diagnosis, treatment, and longterm management of Kawasaki disease : a statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association" 110 : 2747-2771, 2004

7 Keijsers RR, "Cutaneous complication after BCG vaccination : case report and review of the literature" 22 : 315-318, 2011

8 김재홍, "Bacille Calmette-Guérin (BCG) 백신 접종 후 림프절염의 발생 빈도" 대한소아감염학회 23 (23): 54-61, 2016

9 Goraya JS, "Bacille Calmette-Guerin lymphadenitis" 78 : 327-329, 2002

10 김지웅, "BCG 접종부위 근처에 발생한 피부샘병양 BCGitis 1예" 대한피부과학회 46 (46): 298-301, 2008

11 김정민, "BCG 접종부 피부변화를 동반한 비전형적 가와사키병" 대한피부과학회 51 (51): 631-634, 2013

12 배선영, "BCG 접종 후 국소 림프절염의 임상양상" 대한소아감염학회 13 (13): 137-146, 2006

13 권효진, "BCG 림프절염의 임상양상" 대한소아감염학회 16 (16): 80-86, 2009

14 World Health O, "BCG vaccine : WHO position paper, February 2018-Recommendations" 36 : 3408-3410, 2018

15 Alfawaz TS, "BCG related complications : a single center, prospective observational study" 2 : 75-78, 2015

16 Sinha R, "BCG reactivation : a useful diagnostic tool even for incomplete Kawasaki disease" 90 : 891-, 2005

17 Murphy D, "Adverse reactions to Mycobacterium bovis bacille Calmette-Guerin(BCG)vaccination against tuberculosis in humans, veterinary animals and wildlife species" 88 : 344-357, 2008

18 Mahmoudi S, "Adverse reactions to Mycobacterium bovis bacille Calmette-Guerin vaccination against tuberculosis in Iranian children" 4 : 195-199, 2015

19 Nunez-Gussman J, "A report of cutaneous tuberculosis in siblings" 20 : 404-407, 2003